On October 22nd, I wrote an article declaring Omega Healthcare (OHI) as the healthcare REIT sector's value champion. At the $23 market price tag it had around that period of time I believe it was true. However, due to having appreciated to over $29/share it has lost its title as the value champion. Fortunately, a new company, Aviv REIT (AVIV), had its IPO today (3/21/13) and is priced sufficiently low to claim the title. This article will perform fundamental analysis on AVIV and demonstrate it to be a strong buy opportunity.
We could begin by listing its statistics and earnings, but these numbers would mean nothing without framework. We must first form a context from...
Only subscribers can access this article, which is part of the PRO research library covering 3,598 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: